Efficacy of levofloxacin, amoxicillin, bismuth-containing quadruple therapy for helicobacter pylori

被引:0
|
作者
Huang, Sijing [1 ]
Wang, Chengdang [1 ]
机构
[1] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China
关键词
Helicobacter pylori; Drug therapy; Levofloxacin; Bismuth;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:548 / 548
页数:1
相关论文
共 50 条
  • [21] Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication
    Ozturk, Oguzhan
    Doganay, Levent
    Colak, Yasar
    Enc, Feruze Yilmaz
    Ulasoglu, Celal
    Ozdil, Kamil
    Tuncer, Ilyas
    ARAB JOURNAL OF GASTROENTEROLOGY, 2017, 18 (02) : 62 - 67
  • [22] Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori infection: a multicenter, randomized controlled clinical trial
    Mei, Hao
    Guo, Yan
    Zhao, Jing-Tao
    Yang, Jun
    Sun, Wen-jing
    Zhang, De-kui
    He, Ping
    Shi, Gang
    Su, Na-yun
    Han, Ran
    Lan, Chun-Hui
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [23] High Efficacy of 14-Day Triple Therapy-Based, Bismuth-Containing Quadruple Therapy for Initial Helicobacter pylori Eradication
    Sun, Qinjuan
    Liang, Xiao
    Zheng, Qing
    Liu, Wenzhong
    Xiao, Shudong
    Gu, Weiqi
    Lu, Hong
    HELICOBACTER, 2010, 15 (03) : 233 - 238
  • [24] Meta-Analysis of Levofloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy as Second-Line Treatment in the Eradication of Helicobacter pylori
    Marin, Alicia C.
    McNicholl, Adrian G.
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2011, 140 (05) : S880 - S880
  • [25] Meta-Analysis of Levofloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy as Second-Line Treatment in the Eradication of Helicobacter pylori
    Marin, Alicia C.
    McNicholl, Adrian G.
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2012, 142 (05) : S483 - S483
  • [26] Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains
    Muller, Nelly
    Amiot, Aurelien
    Le Thuaut, Aurelie
    Bastuji-Garin, Sylvie
    Deforges, Lionel
    Delchier, Jean-Charles
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2016, 40 (04) : 517 - 524
  • [27] Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days
    Ding, Yu-Ming
    Duan, Miao
    Han, Zhong-Xue
    Song, Xiao-Hui
    Zhang, Feng-Lan
    Wang, Zhi
    Ning, Zhang
    Zeng, Shu-yan
    Kong, Qing-Zhou
    Zhang, Wen-Lin
    Liu, Jing
    Wan, Meng
    Lin, Min-Juan
    Lin, Bo-Shen
    Nan, Xue-ping
    Wang, Hui
    Li, Yue-Yue
    Zuo, Xiu-Li
    Li, Yan-Qing
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (07) : 2540 - 2547
  • [28] BISMUTH-CONTAINING QUADRUPLE THERAPY IN PATIENTS INFECTED BY HELICOBACTER PYLORI: A FIRST REAL LIFE ITALIAN EXPERIENCE
    Tursi, A.
    Franceschi, M.
    De Bastiani, R.
    Elisei, W.
    Baldassarre, G.
    Ferronato, A.
    Grillo, S.
    Landi, S.
    Zamparella, M.
    Boscariolo, L.
    Picchio, M.
    Di Mario, F.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 : E142 - E142
  • [29] Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication
    Huh, Ki Young
    Chung, Hyewon
    Kim, Yu Kyong
    Lee, SeungHwan
    Bhatia, Siddharth
    Takanami, Yohei
    Nakaya, Ryou
    Yu, Kyung-Sang
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (01) : 138 - 144
  • [30] Efficacy of Second-Line Treatment for Helicobacter pylori Infection: Moxifloxacin-Containing Triple Therapy vs. Bismuth-Containing Quadruple Therapy
    Chung, Kwang Hyun
    Lee, Dong Ho
    Kim, Nayoung
    Shin, Cheol Min
    Hwang, Jin Hyeok
    Lee, Sang Hyub
    Lee, Donghyeon
    Oh, Hong Sang
    Jin, Eun Hyo
    GASTROENTEROLOGY, 2012, 142 (05) : S483 - S484